Evidence map›Paper›PMID 33647885›Full record

ArticleAging2021

The networks of m

Xinyu Li, Cheng Peng, Ziqing Zhu, Haozheng Cai, Quan Zhuang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Host mScientific reports · 2026
    Article
  2. Review
  3. Emerging role of N6-methyladenosine RNA methylation in lung diseases.Experimental biology and medicine (Maywood, N.J.) · 2022
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xinyu LiTransplantation Center, The 3rd Xiangya Hospital, Central South University, Changsha 410013, Hunan, China.
Cheng PengDepartment of Plastic Surgery, The 3rd Xiangya Hospital, Central South University, Changsha 410013, Hunan, China.
Ziqing ZhuXiangya School of Medicine, Central South University, Changsha 410013, Hunan, China.
Haozheng CaiTransplantation Center, The 3rd Xiangya Hospital, Central South University, Changsha 410013, Hunan, China.
Quan ZhuangTransplantation Center, The 3rd Xiangya Hospital, Central South University, Changsha 410013, Hunan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease with a poor prognosis. The current coronavirus disease 2019 (COVID-19) shares some similarities with IPF. SARS-CoV-2 related genes have been reported to be broadly regulated by N

Indexed as

Gene Regulatory NetworksAdenosineAlgorithmsCOVID-19HumansIdiopathic Pulmonary FibrosisImmunityImmunity, CellularPrognosisRNARNA, Long NoncodingSARS-CoV-2AdenosineN-methyladenosineRNARNA, Long NoncodingCOVID-19idiopathic pulmonary fibrosisimmuneN6-methyladenosineprognosisSARS-CoV-2

Identifiers

PMID33647885
PMCPMC7993677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.